Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion

Clinical trial NCT01246011 · TERMINATED

Trial details

NCT number

NCT01246011

Sponsor

Massachusetts General Hospital

Status

TERMINATED

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2010-11-01

Primary completion

2011-07-01

Enrollment

9

View on ClinicalTrials.gov